Trinity Biotech
TRIB
37 hedge funds and large institutions have $37.3M invested in Trinity Biotech in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 2 closing their positions.
23% more capital invested
Capital invested by funds: $30.2M → $37.3M (+$7.05M)
0% less ownership
Funds ownership: 0.09% → 0.09% (-0%)
9% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 11
8% less funds holding
Funds holding: 40 → 37 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$289K |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$286K |
| 3 |
FM
Fondren Management
Houston,
Texas
|
+$84.1K |
| 4 |
SCM
Stonehill Capital Management
New York
|
+$50.3K |
| 5 |
Renaissance Technologies
New York
|
+$49.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$489K |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$257K |
| 3 |
BlackRock
New York
|
-$141K |
| 4 |
ARM
Adirondack Research & Management
Guilderland,
New York
|
-$45.8K |
| 5 |
TA
Teton Advisors
Rye,
New York
|
-$29.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Two Sigma Investments
New York
| $29K | -$24.7K | -60 | -47% |
|
27
Northern Trust
Chicago,
Illinois
| $28K | -$825 | -2 | -3% |
|
28
US Bancorp
Minneapolis,
Minnesota
| $18K | -$11.1K | -27 | -39% |
|
|
WAS
29
WESPAC Advisors SoCal
Pasadena,
California
| $14K | – | – | – |
|
|
ECM
30
Engine Capital Management
New York
| $12K | – | – | – |
|
31
Bank of Montreal
Toronto,
Ontario, Canada
| $9K | – | – | – |
|
|
JCM
32
Jacobi Capital Management
Pittston,
Pennsylvania
| $6K | – | – | – |
|
33
Bank of America
Charlotte,
North Carolina
| $6K | +$2.89K | +7 | +117% |
|
34
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
LTFS
35
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
36
BlackRock
New York
| – | -$141K | -409 | Closed |
|
|
WS
37
Wedbush Securities
Los Angeles,
California
| – | -$27K | -79 | Closed |
|
TRIB Hedge Fund Activity: Q1 2019 in Review
37 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q1 2019, worth a combined $37.3M — up 23% from $30.2M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TRIB and 0 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 10 added.
The largest buyer was Hunter Associates Investment Management, adding an estimated $289K. The largest seller was Janus Henderson Group, cutting an estimated $489K.
- 37 institutional investors held Trinity Biotech (TRIB) as of Q1 2019, down from 40 in Q4 2018.
- Funds reported $37.3M of Trinity Biotech stock for Q1 2019, up 23% quarter-over-quarter.
- 0 funds opened new Trinity Biotech positions in Q1 2019 and 2 closed out, a net change of -2 holders.
- The largest Trinity Biotech buyer in Q1 2019 was Hunter Associates Investment Management, an estimated $289K added.
- The largest Trinity Biotech seller in Q1 2019 was Janus Henderson Group, an estimated $489K sold.
Based on aggregated 13F filings for Q1 2019.